Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.
2.
3.

The clinical-economic trial: promise, problems, and challenges.

Powe NR, Griffiths RI.

Control Clin Trials. 1995 Dec;16(6):377-94. Review.

PMID:
8720016
4.

Computerized automation of clinical trials.

Johnson N, Lilford RJ.

Baillieres Clin Obstet Gynaecol. 1990 Dec;4(4):771-86. Review.

PMID:
2289365
5.

Data collection in clinical toxicology: are there too many variables?

Whyte IM, Buckley NA, Dawson AH.

J Toxicol Clin Toxicol. 2002;40(3):223-30. Review.

PMID:
12144195
6.

On design considerations and randomization-based inference for community intervention trials.

Gail MH, Mark SD, Carroll RJ, Green SB, Pee D.

Stat Med. 1996 Jun 15;15(11):1069-92. Review.

PMID:
8804140
7.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

8.

Randomized clinical trials in medical rehabilitation research.

Tate DG, Findley T Jr, Dijkers M, Nobunaga AI, Karunas RB.

Am J Phys Med Rehabil. 1999 Sep-Oct;78(5):486-99. Review.

PMID:
10493460
9.

Quality assessment in clinical trials: considerations for outcomes research in interventional pain medicine.

Hartrick CT.

Pain Pract. 2008 Nov-Dec;8(6):433-8. doi: 10.1111/j.1533-2500.2008.00235.x. Epub 2008 Sep 8. Review.

PMID:
18783359
10.

Conducting clinical trials to establish drug efficacy in chronic pain.

Harden RN, Bruehl S.

Am J Phys Med Rehabil. 2001 Jul;80(7):547-57. Review.

PMID:
11421526
11.
12.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
13.

Current research in statistical methodology for clinical trials.

Meier P.

Biometrics. 1982 Mar;38 Suppl:141-53. Review.

PMID:
7046819
14.

Methodological advances and plans for improving regulatory success for confirmatory studies.

Koch GG, Davis SM, Anderson RL.

Stat Med. 1998 Aug 15-30;17(15-16):1675-90. Review.

PMID:
9749439
15.
16.

[Methodological and statistical aspects of equivalence and non inferiority trials].

Elie C, De Rycke Y, Jais JP, Marion-Gallois R, Landais P.

Rev Epidemiol Sante Publique. 2008 Aug;56(4):267-77. doi: 10.1016/j.respe.2008.05.027. Epub 2008 Aug 13. Review. French.

PMID:
18703296
17.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

18.

The method of minimization for allocation to clinical trials. a review.

Scott NW, McPherson GC, Ramsay CR, Campbell MK.

Control Clin Trials. 2002 Dec;23(6):662-74. Review.

PMID:
12505244
19.

A systematic review of faculty development initiatives designed to improve teaching effectiveness in medical education: BEME Guide No. 8.

Steinert Y, Mann K, Centeno A, Dolmans D, Spencer J, Gelula M, Prideaux D.

Med Teach. 2006 Sep;28(6):497-526. Review.

PMID:
17074699
20.

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

Talley NJ.

Gastroenterology. 1994 May;106(5):1174-83. Review.

PMID:
8174880
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk